Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    O04 - Molecular Pathology I

    • Type: Oral Abstract Session
    • Track: Pathology
    • Presentations: 8
    • Moderators:I.I. Wistuba
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
    • +

      O04.05 - Epidemiology of PI3K pathway alterations in patients with metastatic non-small cell lung cancer (NSCLC): findings from the international BASALT-1 study

      11:15 - 11:25  |  Author(s): G.K. Dy

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.24 - Poster Session 3 - Supportive Care

    • Type: Poster Session
    • Track: Supportive Care
    • Presentations: 54
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.24-030 - Activity and tolerability of carboplatin and gemcitabine in first-line treatment of elderly Thai patients with advanced non-small cell lung cancer (NSCLC).

      09:30 - 09:30  |  Author(s): C.-. Charoentum

      • Abstract

      Loading...

    • +

      P3.24-035 - Evaluating health related quality of life and symptoms by using the electronic (ePRO) version of the LCSS (eLCSS-QL) in a 622 patient prospective multinational NSCLC trial (AP-QL Trial) with good cross-cultural reliability.

      09:30 - 09:30  |  Author(s): S. Thongprasert

      • Abstract

      Loading...

  • +

    MS19 - New Health Technology for Lung Cancer; Assessment and Implementation

    • Type: Mini Symposia
    • Track: Radiation Oncology + Radiotherapy
    • Presentations: 5
    • Moderators:Y. Lievens
    • Coordinates: 10/30/2013, 14:00 - 15:30, Parkside Ballroom B, Level 1